Martin and Harris Laboratories: Financial Results for FY24

08 November 2024

• Revenue- In FY24, the company's revenue dropped by 29%, declining from Rs. 205 cr in FY23 to Rs. 146 cr, primarily due to a decrease in goods sales. Additionally, the company's net income fell by 41%, going from Rs. 68 cr in FY23 to Rs. 40 cr in FY24, which led to a 41% reduction in EPS, down from Rs. 170 in FY23 to Rs. 101 in FY24.
• Financial Position- The company's total assets grew by 8%, rising from Rs. 615 cr in FY23 to Rs. 662 cr in FY24. Similarly, total equity increased by 7%, moving from Rs. 593 cr in FY23 to Rs. 632 cr in FY24.